Showing papers by "Timothy Z. Keith published in 2013"

WAIS-IV and Clinical Validation of the Four- and Five-Factor Interpretative Approaches

Abstract: The fourth edition of the Wechsler Adult Intelligence Scale (WAIS-IV) is a revised and substantially updated version of its predecessor. The purposes of this research were to determine the construc...

Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial.

Abstract: Several meta-analyses and a Cochrane review indicate that additional clinical trials are needed to guide clinical practice decisions around the use of non-hormonal therapies for vasomotor symptoms (i.e., hot flashes, night sweats).1–4 Trials are needed to generate a sufficient evidence-base to guide clinical treatment decisions concerning use of non-hormonal therapies for vasomotor symptoms. As many as 80% of women experience vasomotor symptoms and nearly 20% find them intolerable.5 Sudden rushes of heat and sweating are often accompanied by increased heart rate, chills, shivering, clamminess, anxiety, feelings of nausea, a “head-ache”-like sensation, visible reddening and blotching of the face and neck, an increase in core body temperature, increased metabolism, and interrupted sleep.6–18 Symptoms generally wane five to seven years post menopause,19 but can persist in some women for over 20 years; with median symptom duration of approximately four years.20 Alternate non-hormonal pharmacotherapy, such as clonidine, gabapentin, and paroxetine, appear promising, but side-effects and cost can diminish long-term compliance. Clinical hypnosis, a mind-body therapy designed to facilitate a hypnotic state, coolness and control of symptoms, appears promising, however no large scale, randomized, controlled trials have yet been published. Pilot data showed breast cancer survivors who received five weekly sessions of clinical hypnosis experienced a 69% reduction in hot flashes relative to baseline.21 These results are comparable or superior to results of open label studies with paroxetine and venlafaxine. 22,4,23–25 Thus, the purpose of this randomized controlled trial was to evaluate clinical hypnosis against structured attention control for the treatment of hot flashes in post-menopausal women. Primary outcomes were hot flash frequency (perceived and physiologically measured) and hot flash score (diary frequency × severity). Secondary outcomes were hot flash interference, sleep quality, and treatment satisfaction.

Technical and Practical Issues in the Structure and Clinical Invariance of the Wechsler Scales: A Rejoinder to Commentaries.

Abstract: This discussion article addresses issues related to expansion of the Wechsler model from four to five factors; multiple broad CHC abilities measured by the Arithmetic subtest; advantages and disadv...

A Pilot Investigation of Guided Self-Hypnosis in the Treatment of Hot Flashes Among Postmenopausal Women

Abstract: Previous research has demonstrated that a hypnotic intervention can reduce hot flashes, a significant problem for some women. Based on the authors' previous research, the present study was developed to evaluate the feasibility of a guided self-hypnosis intervention for hot flashes. Thirteen postmenopausal women received 5 sessions of guided self-hypnosis in which all hypnotic inductions were recordings. Guidance regarding symptom monitoring, individualization of mental imagery, and practice of self-hypnosis were provided. Hot flashes were determined through diaries. Results indicated average frequency of hot flashes decreased by 72% (p < .001) and hot-flash scores decreased by 76% (p < .001) on average. Guided self-hypnosis reduced perceived hot flashes in the pilot study with postmenopausal women supporting the possible feasibility and potential benefit of the intervention.